Herbas VPB

Print
EN | LT
LT - COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR
EN - COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
C07K 16/2878 (2013.01)
A61P 35/02 (2006.01)
A61K 47/6849 (2017.08)
A61K 47/68 (2017.01)
A61P 35/02 (2018.01)
A61K 39/00 (2006.01)
A61K2039/505 (2013.01)
C07K2317/00 (2013.01)
C07K2317/76 (2013.01)
A61K 47/68031 (2023.08)
European patent
(11) Number of the document 3953387
(13) Kind of document T
(96) European patent application number 20719739.3
Date of filing the European patent application 2020-04-09
(97) Date of publication of the European application 2022-02-16
(45) Date of publication and mention of the grant of the patent 2024-07-03
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2020/053397
Date 2020-04-09
PCT application publication
(87) Number WO 2020/208572
Date 2020-10-15
Priority applications
(30) Number Date Country code
201962831913 P 2019-04-10 US
201962943480 P 2019-12-04 US
Inventors
(72)
BISWAS, Swethajit , US
HOLKOVA, Beata , US
LUPTAKOVA, Katarina , US
Grantee
(73) GlaxoSmithKline Intellectual Property Development Ltd , GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Springworks Therapeutics, Inc. , 100 Washington Blvd. 5th Floor, Stamford, CT 06902, US
Title
(54) COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR
  COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR